pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D

Naturally occurring mutations in the polymerase gene of human immunodeficiency virus type 1 (HIV-1) have important implications for therapy and the outcome of clinical studies. Using 42 virus isolates obtained from the UNAIDS sample collection, we analyzed the protease (99 amino acids [aa]) and the first 297 aa of reverse transcriptase (RT) coding regions. Based on the V3 sequence analysis, the collection includes subtype A (n = 5), subtype B (n = 12), subtype C (n = 1), subtype D (n = 11), and subtype E (n = 13) viruses. Of the 42 protease genes, 37 contained naturally occurring mutations at positions in the gene that contribute to resistance to protease inhibitors (indinavir, saquinavir, ritonavir, and nelfinavir) in clade B isolates. The phenotypic effect of these substitutions in non-B isolates is unclear. The The 5'half RT coding region of the 42 isolates was found to be less variable, although 19 of the 42 RT sequences contained amino acid substitutions known to contribute to nucleoside and/or nonnucleoside drug resistance. Since the virus isolates were obtained in 1992, it is unlikely that the infected subjects received protease inhibitors, but we found evidence that one subject acquired a zidovudine (AZT)-resistant HIV-1 strain from a contact who had received AZT. Phylogenetic analysis identified five subtype pol clusters: A, B, C, D, and A'. Comparison of env and pol sequences of the same viruses showed no more recombination events than were already identified on the basis of gag/env comparison (M. Cornelissen, G. Kampinga, F. Zorgdrager, J. Goudsmit, and the UNAIDS Network for HIV Isolation and Characterization, J. Virol. 70:8209-8212, 1996). In one of the known recombinants, a crossover site between subtypes A and C could be identified, and in another, a crossover site could not be identified due to lack of a reference subtype F pol sequence. We analyzed the ds/da ratio of gag, pol, and env sequences of 35 isolates, excluding the recombinants. Our analysis showed that gag and pol are subjected to purifying selection with an average ds/da ratio above 1, independent of the subtype and in contrast with V3 (ds/da approximately 1). Based on the low ds/da ratio of the intergroup analysis of A/E and B/D gag and pol sequences, we analyzed the evolutionary relation between subtypes B and D in more detail by constructing separate phylogenetic trees for synonymous and nonsynonymous substitutions. Our analysis suggests a common ancestry for subtypes B and D that is distinct from that of subtypes A and E.

[1]  E. Karita,et al.  Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. , 1997, Virology.

[2]  Wei-Shau Hu,et al.  Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Andrew Carr,et al.  HIV protease inhibitors , 1996, AIDS.

[4]  M. Nei,et al.  MEGA: Molecular Evolutionary Genetics Analysis, Version 1.02. , 1995 .

[5]  N. Shen,et al.  Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arrays , 1996, Nature Medicine.

[6]  E. G. Shpaer,et al.  Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil , 1994, Journal of virology.

[7]  J. Coffin,et al.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.

[8]  B. Korber,et al.  The World Health Organization Global Programme on AIDS Proposal for Standardization of HIV Sequence Nomenclature , 1994 .

[9]  H. Gayle,et al.  Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand , 1993, The Lancet.

[10]  C. Dauguet,et al.  Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. , 1996, Virology.

[11]  J. Goudsmit,et al.  Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization , 1996, Journal of virology.

[12]  Brendan A. Larder,et al.  Site-specific mutagenesis of AIDS virus reverse transcriptase , 1987, Nature.

[13]  J. Condra,et al.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors , 1995, Nature.

[14]  J. Sodroski,et al.  Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization , 1996, Journal of virology.

[15]  S. Ray,et al.  Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression , 1995, Journal of virology.

[16]  C. Kuiken,et al.  Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period , 1995, Journal of virology.

[17]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[18]  A S Perelson,et al.  Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase , 1996, Journal of virology.

[19]  J S Sinsheimer,et al.  In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects , 1996, Journal of virology.

[20]  J. Coffin Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. , 1979, The Journal of general virology.

[21]  W. Farmerie,et al.  Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. , 1996, Virology.

[22]  B. Larder,et al.  Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. , 1992, The Journal of infectious diseases.

[23]  M. Busch,et al.  Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group , 1995, Journal of virology.

[24]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[25]  D W Barry,et al.  3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Mellors,et al.  Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor , 1996, Journal of virology.

[27]  D. Ho,et al.  Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Sharp,et al.  Recombination in HIV-1 , 1995, Nature.

[29]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[30]  L. M. Mansky,et al.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.

[31]  E. Holmes,et al.  Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Sodroski,et al.  Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses , 1996, Journal of virology.

[33]  H Hui,et al.  The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin , 1996, Journal of virology.

[34]  Wei-Shau Hu,et al.  Retroviral recombination and reverse transcription. , 1990, Science.

[35]  Marianne Manchester,et al.  Complete mutagenesis of the HIV-1 protease , 1989, Nature.

[36]  E. Domingo,et al.  Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy , 1995, Journal of virology.

[37]  D. Burke,et al.  Genetic variants of HIV-1 in Thailand. , 1992, AIDS research and human retroviruses.

[38]  D. Ho,et al.  Ordered accumulation of mutations in HIV protease confers resistance to ritonavir , 1996, Nature Medicine.

[39]  N. Torre,et al.  Wide distribution of two subtypes of HIV-1 in Thailand. , 1992, AIDS research and human retroviruses.

[40]  M. Uhlén,et al.  Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. , 1995, Virology.